FDA's latest on J&J vaccine safety concerns and more with Andrea Garcia, JD, MPH | COVID-19 Update
FDA's latest on J&J vaccine safety concerns and more with Andrea Garcia, JD, MPH | COVID-19 Update
AMA CXO Todd Unger discusses the latest Johnson & Johnson COVID vaccine news with AMA Director of Science, Medicine and Public Health, Andrea Garcia. Also covering a newly released estimate for COVID-19 related deaths using excess mortality, as well as summer spikes of coronavirus cases, hospitalizations, and that masking up in airports or high-risk settings continues to reduce chances of COVID infection.0:00 AMA COVID-19 Update for May 11, 2022
0:28 FDA announced it was furthering limiting J&J's COVID vaccine use citing safety concerns
1:20 What risks or side effects are associated with the J&J vaccine?
2:43 New estimates calculated by panel of experts from WHO using excess mortality, reported nearly 15 million more people died during the first two years of the pandemic
3:13 What caused such a vast undercount in deaths previously?
4:05 Were all of those excess deaths attributed to COVID?
5:27 Recent reports show new COVID cases have doubled in the past month
6:26 COVID hospitalizations are also on the rise, up 20% from two weeks ago
7:36 Experts recommend that people test frequently if mixing in large groups; wearing well-fitted N95, KN95, or KF9 mask can provide extra protection
8:45 CDC continues to recommend masks when traveling or riding public transportation; masking up in higher risk settings like airports reduce chances COVID infection
10:13 Will there be another wave of COVID surges in the months ahead?
Stay up to date on the latest information about the pandemic: https://ama-assn.org/covid-19-resources.
Visit the COVID-19 Daily Video Updates page for more videos in this series: https://ama-assn.org/covid-19-videos.
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.